In ESCC from two medium-incidence areas of the disease (South eastern Brazil and South eastern France), a frequency of about 34% of TP53 mutations was observed and the mutation profile showed a high percentage of alterations at A:T base pairs [16,17]. This evidence concerns the gene TP53 and esophageal squamous cell carcinoma.